The Future of Computing: Human Brain Cells as Living Hardware
As prominent artificial intelligence (AI) researchers begin identifying limits within the current phase of technology, a radically different approach is capturing attention: utilizing living human brain cells as computational hardware. These so-called "biocomputers" are still in their infancy, yet they have already demonstrated capabilities such as playing simple games like Pong and performing elementary speech recognition tasks.
The Convergence of Trends Fuelling Biocomputing
Interest in biocomputers is driven by three converging trends:
- Venture Capital Surge: Funding is streaming into any initiative that relates to AI, making speculative ideas suddenly viable.
- Advances in Growing Brain Tissue: The pharmaceutical industry has helped refine techniques for cultivating brain tissue outside the body, enhancing the feasibility of biohybrid systems.
- Rapid Brain–Computer Interface Developments: Technologies that blur the lines between biology and machines are increasingly accepted, paving the way for integration.
However, critical questions remain. Are we witnessing groundbreaking technological advancements or merely the cyclical hype of the tech industry? Furthermore, how should we grapple with the ethical challenges that arise when human brain tissue is employed as a component of computing systems?
Understanding the Technology: A Historical Context
For nearly 50 years, neuroscientists have been growing neurons on tiny electrode arrays to study their firing patterns in controlled environments. In the early 2000s, early attempts were made to establish two-way communication between neurons and electrodes, laying the groundwork for bio-hybrid computers. Yet, advancements stalled until the emergence of brain organoids.
In 2013, researchers revealed that stem cells could self-organize into three-dimensional, brain-like structures, fueling a multitude of biomedical research applications. These organoids quickly found their place in a variety of studies, supported by “organ-on-a-chip” technologies simulating human physiology beyond laboratory confines. Although the neural activity within these models is still quite primitive, it signals a step toward more complex interactions.
More Read
The Rise of “Organoid Intelligence”
The field gained significant momentum in 2022, when Melbourne-based Cortical Labs published a study documenting cultured neurons that learned to play Pong via a closed-loop system. This experiment sparked considerable media interest, particularly due to the term “embodied sentience” used in the study. Many neuroscience experts cautioned against the language employed, claiming it overstated the capabilities of the system and raised ethical concerns about misleading interpretations.
The following year saw the introduction of the broader term "organoid intelligence," a catchy phrase that has gained media traction but fails to reflect the vast differences between current organoid systems and artificial intelligence. Urgent updates to ethical guidelines are essential, as existing bioethics frameworks primarily view brain organoids as biomedical tools, not biohybrid computing components.
The Evolving Landscape of Research and Commercialization
A burgeoning race to develop biohybrid computing systems is evident among companies and academic groups across the globe—ranging from the United States to Switzerland to China and Australia. Swiss firm FinalSpark is already providing remote access to its neural organoids, while Cortical Labs is preparing to launch a desktop biocomputer, the CL1. The anticipated clientele includes not only pharmaceutical companies, but also AI researchers searching for innovative computing solutions.
Moreover, ambitious academic initiatives are proliferating. For instance, researchers at UC San Diego have set their sights on using organoid-based systems to forecast oil spill trajectories in the Amazon by 2028. Over the next few years, we will learn whether organoid intelligence will revolutionize computing or become a fleeting novelty. At present, the assertion of sentience remains unsupported; today’s systems can only exhibit basic adaptive responses, lacking the higher cognitive functions associated with advanced intelligence.
Practical Applications in Neuroscience and Toxicology
Current efforts are more focused on refining prototype systems, scaling them effectively, and identifying practical applications for the technology. Several research teams are examining organoids as a potential alternative to animal models in neuroscience and toxicology. One group has proposed frameworks to study how various chemicals impact early brain development, while other studies demonstrate enhanced predictions of epilepsy-related brain activity through neural and electronic system connections. These incremental advances offer promising implications for future research.
Navigating the Broader Questions
What makes the intersection of biotechnology and computing so both compelling and unsettling is the broader societal context. As billionaires like Elon Musk chase ambitious visions of neural implants and transhumanism, organoid intelligence raises profound questions: What defines intelligence? At what threshold might a network of human cells merit moral consideration? How should society regulate biological systems that exhibit, even in limited capacities, behaviors akin to small computers?
Although the technology remains in its nascent stages, its evolving trajectory indicates that discussions surrounding consciousness, personhood, and the ethics of using living tissue as computational tools will become increasingly pressing. As we navigate these uncharted waters, the implications of merging biology with technology continue to captivate scientists, ethicists, and policymakers alike.
Inspired by: Source
